# International cooperation in public health in Martinique geostrategic utility for cancer surveillance in the Caribbean

Clarisse Joachim, Thierry Almont, Moustapha Drame, Cédric Contaret, Mylène Vestris, Fatiha Najioullah, Aude Aline-Fardin, Patrick Escarmant, Nicolas Leduc, Nathalie Grossat, et al.

<figure><img src="image_1.png" /></figure>

## ► To cite this version:

Clarisse Joachim, Thierry Almont, Moustapha Drame, Cédric Contaret, Mylène Vestris, et al. International cooperation in public health in Martinique geostrategic utility for cancer surveillance in the Caribbean. Globalization and Health, 2020, 16 (1), pp.20. 10.1186/s12992-020-00551-w. hal-02532847

HAL Id: hal-02532847

https://univ-rennes.hal.science/hal-02532847v1

Submitted on 6 Apr 2020

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
# International cooperation in public health in Martinique: geostrategic utility for cancer surveillance in the Caribbean

<figure><img src="image_3.png" /></figure>

Check for
updates

Clarisse Joachim<fnref n="1" />*, Thierry Almont², Moustapha Drame³, Cédric Contaret⁴, Mylène Vestris<fnref n="1" />, Fatiha Najioullah⁵, Aude Aline-Fardin⁶, Patrick Escarmant⁷, Nicolas Leduc⁷, Nathalie Grossat⁷, Xavier Promeyrat⁷, Stefanos Bougas⁷, Eva Papadopoulou⁷, Vincent Vinh-Hung⁷, Emmanuelle Sylvestre⁸,⁹,¹⁰,¹¹ and Jacqueline Veronique-Baudin¹²

**Abstract**

**Background:** Cooperation in public health and in oncology in particular, is currently a major issue for the island of Martinique, given its geopolitical position in the Caribbean region. The region of Martinique shares certain public health problems with other countries of the Caribbean, notably in terms of diagnostic and therapeutic management of patients with cancer. We present here a roadmap of cooperation priorities and activities in cancer surveillance and oncology in Martinique.

**Main body:** The fight against cancer is a key public health priority that features high on the regional health policy for Martinique. In the face of these specific epidemiological conditions, Martinique needs to engage in medical cooperation in the field of oncology within the Caribbean, to improve skills and knowledge in this field, and to promote the creation of bilateral relations that will help to improve cancer management in an international healthcare environment.

**Conclusions:** These collaborative exchanges will continue throughout 2020 and will lead to the implementation of mutual research projects across a larger population basin, integrating e-health approaches and epidemiological e-cohorts.

**Keywords:** Cancer, Cooperation, Epidemiology, Caribbean

**Introduction**

Cooperation is a major component of France's worldwide public health efforts that aim to improve health for people all over the globe. Far from being limited to humanitarian activities, international hospital cooperation is developing in all hospital-related domains. Because the hospital is at the heart of the healthcare system, international hospital cooperation is one of the means of implementing public assistance targeting health.

Cooperation in public health and in oncology in particular, is currently a major issue for the island of Martinique. Martinique, a region of France, is located in the Lower Antilles of the West-Indies in the Caribbean. The island covers an area of 1128 km² with a population of 383,910 as of 2014 [1]. Given its geopolitical position in the Caribbean region, Martinique shares certain public health problems with other countries of the Caribbean, notably in terms of diagnostic and therapeutic management of patients with cancer [2]. Indeed, there is a high prevalence of chronic diseases (cancer, type 2 diabetes, arterial hypertension, stroke and end-stage kidney failure) in Martinique. As in the neighbouring island of

<footnote>* Correspondence: Clarisse.joachim@chu-martinique.fr</footnote>

<footnote n="1">¹CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 1441
Registre des cancers, Martinique F-97200, France</footnote>

<footnote>Full list of author information is available at the end of the article</footnote>
Guadeloupe, Martinique suffers from a pronounced shortfall of women in the 18 to 39 year age bracket, and of men in the 20 to 40 year age group. Accordingly, only 21% of the Martinique population is aged between 20 and 40 years, versus 25% in mainland France. The ageing of the population has accelerated notably in the last two decades in Martinique. In 1990, 68% of the population was aged under 40, compared to only 45% now [3, 4].

In Martinique, a total of 1583 new cases of cancer are recorded per year (all sites considered), of which 61% occur in men, with a male/female sex ratio of 1.5 [5]. With world-standardized incidence rates of 301.6 per 100,000 person-years in men, and 168.4 in women, Martinique counts among the regions of France with the lowest overall incidence of all cancers, along with Guadeloupe and French Guyana. In men, the most common type of cancer is prostate cancer (55%), accounting for more than half of new cancer cases each year, well ahead of colorectal (9%) and stomach (4%) cancer. In women, the most common type of cancer is breast cancer (33%), well ahead of colorectal (14%), stomach and cervical cancer (5% each). A total of 729 cancer-related deaths occurred per year, of which 56% were in men. This situation compares favourably with mainland France (all sites considered) with an incidence that is 15% lower in men and 34% lower in women. Mortality is 18% lower in men and 8% lower in women in Martinique [6].

However, the distribution of these cancers differs from that of mainland France, with large disparities for certain cancer localisations, such as the prostate [7–9], cervical cancer [10], stomach and multiple myeloma.

The ethno-geographic and socio-demographic characteristics in this population of mainly Afro-Caribbean origin could partially explain these disparities. However, other factors also deserve to be investigated, including: 1) increased rates of smoking, particularly in women; 2) Changes in lifestyle and eating habits that have led to a high rate of obesity, a known risk factor for cancer, especially colorectal cancer; 3) Environmental pollution by pesticides, particularly chlordecone, which warrants further research in cancer sites other than the prostate; 4) The role of oncogenic infectious agents also deserves investigation, such as the human papillomavirus and its genotypes circulating in the Caribbean, which are associated with a high risk of cervical cancer; as well as also Helicobacter pylori and the risk of stomach cancer. These factors may be implicated in the pathogenesis or exacerbation of these cancers [11–14].

Successive national cancer plans in France have developed priority actions to be implemented for the management of these patients [15], and these actions can also be integrated into overall healthcare delivery strategies at the level of the Region of Martinique [16, 17], and in the Caribbean in general.

In the face of these specific epidemiological conditions, Martinique needs to engage in medical cooperation in the field of oncology within the Caribbean. Cooperation is necessary to improve skills and knowledge in this field, to pool human and material resources, and to promote the creation of bilateral relations that will help to improve cancer management in an international healthcare environment.

We present a roadmap of cooperative activities in cancer surveillance and oncology in Martinique.

# Main text

## Structuring medical and scientific cooperation in Martinique

### The main players in international cooperation for Martinique's development

The international community via the United Nations Organisation has developed 17 Sustainable Development Goals to be achieved by 2030. Health, and its determinants, are mentioned in 12 of these 17 goals. In particular, goal 3 (“Good health and well-being”) aims to ensure healthy lives and promote well-being for all, at all ages. France is a member of the Executive Committee of the World Health Organization (WHO), a participating state in the Pan American Health Organisation (PAHO), and an observer in the Regional Office for Africa (AFRO). The partnership agreement signed between France and the WHO defines several priority domains for cooperation, including [1] sanitary security [2]; development goals related to health, and [3] the reduction of risk factors in relation to non-communicable diseases and environmental determinants of health, such as exposure to chemicals, domestic and professional exposure, access to care, education, income, etc. [18].

The countries of the Caribbean are characterized by a number of epidemiological and environmental specificities, as compared with France. These include a higher prevalence of chronic diseases, different population age pyramids, environmental exposure to pollutants, and exposure to extreme meteorological phenomena. France has committed to undertaking cooperative actions in the regions of Martinique, Guadeloupe and French Guyana, that could integrate public health campaigns at the regional level [19, 20]. In the cancer plan, in particular, some actions have been undertaken with the overseas Departments and have already led to the definition of operational objectives for collaborative work in the fight against cancer [15].

At the level of the Caribbean, France has undertaken cooperative programmes with member countries of the Organisation of Eastern Caribbean States (OECS), of which Martinique has been a member since 2015 [21]. The presence of representatives of French research and public health within organisations, platforms and international
networks dedicated to health makes it possible to highlight and strategically position France, and French-language expertise in the Caribbean.

Among the major players in medical and scientific cooperation in the field of cancer in Martinique, are the International Cooperation Direction of the University Hospital of Martinique, the Regional Agency for Health, the population based-cancer registry of Martinique (international registry, grade A, created in 1983), the medical divisions of Oncology – Haematology – Urology and the Research Unit for Cancer – Haematology.

To initiate cooperative programmes, it is first necessary to identify medical teams in oncology, and to designate reference medical and scientific persons in charge of cooperation, in the framework of inter-hospital partnership agreements. Cuba, Puerto Rico [22], Dominican Republic as well as the Eastern Caribbean Diagnostic Oncology Network (EC-DON) and the Caribbean Hub of cancer registries are priority targets for cooperative actions. In the long-term, mapping the major players and mapping healthcare pathways for cancer patients in the Caribbean will contribute to widening our knowledge of cancer epidemiology in this zone. These attempts to map healthcare processes in the framework of cooperative efforts in oncology can serve as a model for other medical specialities in Martinique.

Through its presence in large international organisations, both globally and in the Caribbean region, France is striving to create the structural conditions that are amenable to successful cooperation between Martinique and its neighbours.

## Cooperation in cancer surveillance: state of the art in Martinique

### Healthcare delivery in oncology in Martinique

Within the Caribbean, Martinique counts among the leaders in the development of oncology services thanks to the implementation of a polyvalent and efficient healthcare system that enables all-round, personalized care for patients with cancer.

Hospital admissions in the disciplines of medicine, surgery and obstetrics, expressed relative to the number of inhabitants, are actually lower in Martinique than in metropolitan France. The hospitalization rate varies from 12.4 to 14.1 stays per 100 inhabitants in the French Overseas Departments, compared to an average of 15.7 stays per 100 inhabitants in mainland France. In 2015, the average length of stay in Martinique was slightly higher than in mainland France (respectively 6.2 vs 5.7 days) [23].

The University Hospital of Martinique comprises clinical and medico-technical divisions that cover the main medical, surgical and obstetrical disciplines. The hospital also disposes of beds for dependent elderly persons, and

long-term care units. The total capacity of the hospital is 1426 beds, and 120 places, with a total of 5200 employees from a wide range of professions to ensure quality healthcare is delivered. The Oncology – Haematology – Urology division of the University Hospital of Martinique brings together the main healthcare structures for cancer in Martinique, and currently regroups all medical, scientific and paramedical players in the field of oncology. This Division is the reference centre for the treatment of adult cancers in Martinique as regards radiotherapy, medical oncology, haematology and urology. For example, the acquisition of tomotherapy has opened up access to innovative technologies, making it possible to delivery higher doses of radiation to the tumour, while sparing surrounding organs.

### Martinique and its integration at Caribbean level

The University Hospital of Martinique receives several hundred patients per year from abroad, most of whom come from the countries of the OECS (Dominica, Grenada, Saint Lucia), 54% of them come from Saint Lucia alone [24]. Most are hospitalized for more than 24 h, although outpatient admissions are also increasing steadily. According to diagnosis related groups-based analysis, the most common disease treated in these incoming patients is cancer (outpatient sessions for radiation, chemotherapy, tomotherapy and other techniques). Martinique sees fewer patients leave the island to seek healthcare services elsewhere as compared to Guadeloupe or French Guyana.

In terms of cancer surveillance, the Oncology – Haematology – Urology division of the University Hospital of Martinique received funding in 2018 to create a digital platform for cooperation with existing or future cancer registries in the Caribbean. The objective is to pool data from all Caribbean cancer registries to enhance cancer surveillance. A second phase of this project with clinical implementation of new cancer treatments is emerging.

Through these and other projects, the level of cooperation and integration between Martinique and its Caribbean neighbours is steadily growing.

### Strategy for cooperation in oncology in Martinique

Cooperative projects have been conducted in the Caribbean through initiatives such as medical cooperation in the Caribbean [25], and networks for cancer surveillance in the region [26, 27]. The theme of cooperation in the field of cancer is a major challenge for the Caribbean countries that require investment for the implementation of cancer care strategies [28]. Multicenter studies integrating data from Caribbean cancer registries have also been conducted, with a view to scientific and international cooperation [29].
In the field of oncology, cooperation involves a wide spectrum of equipment, resources, and reference healthcare options, as well as mobility of physicians, and for many years, has covered the areas of prevention, training and research. This cooperation has been flourishing particularly in border regions that share similar epidemiological characteristics. Historically, from 1981 to 1990, in collaboration with the Ministry for Health, the oncology division and its partners started offering advanced consultations every trimester, and were increasingly called upon to manage and follow-up cancer patients from neighbouring countries. Cooperation between hospitals and universities is one avenue towards increasing the numbers of health professionals, by establishing bilateral partnerships and programmes between countries in the Caribbean. For example, the possibility for medical residents (i.e. specialists in training) from other Caribbean countries to train in Martinique in specialties such as haematology, radiotherapy or public health, makes it possible to maintain a certain level of stability in the healthcare workforce. This is fundamentally important for the fight against cancer, where substantial staff turnover can hamper delivery of care, which may in turn be harmful for patients.

Telemedicine (telepathology and telediagnosis) is currently being widely developed in Martinique. These new possibilities for exchange and communication will enable transverse management of patients at the loco-regional and Caribbean levels for the diagnosis and follow-up of patients with cancer. The problem of medical demographics is pressing, and cooperation between healthcare professionals is a major issue for the Caribbean to enable all countries to benefit from the presence of qualified professionals in neighbouring countries.

Another key issue driving the need for cooperation is to study the epidemiological specificities of the Caribbean region (e.g. high incidence of prostate and stomach cancer and myeloma, exposure to pesticides, effect of obesity...). We need to define shared research focuses in chronic and emerging diseases, and pool our human, financial and material resources through the creation of centres of excellence.

Lastly, childhood cancer care in Latin America and the Caribbean is also a major objective in our region. The PAHO Childhood Cancer Working Group was created in 2017 to support the development of childhood cancer care through structured knowledge exchange, capacity building, and collaboration [30]. The SickKids-Caribbean Initiative was created in 2013 for the care of children with cancer and blood disorders in partnership with the University of the West-Indies, Ministries of Health and health institutions; the aim is to improve outcomes and quality of life for children with cancer [31].

## Funding for cooperative actions in Martinique

The Ministry for Health, through the Directorate of Health Care Supply (Direction Générale de l'Offre de

Soins), finances hospital initiatives through annual calls for projects that attribute funds to healthcare establishments (missions of general interest, and funding for cooperative partnerships). The contribution from each healthcare establishment generally covers the expenses related to welcoming visiting students or healthcare professionals for internships or exchanges.

The territorial authorities, particularly the administrations of individual cities and regions, count among the first-line local partners of healthcare establishments in terms of international cooperation. Hospital-based initiatives taking place in the framework of these partnerships are among the geographical and thematic priorities for decentralised cooperation, and are also important for cohesion policies among local and/or regional authorities. The European Union also offers its own range of financing possibilities, as well as specific geographic instruments such as the European Development Fund, or programmes for cross-border and inter-regional cooperation (INTERREG). The INTERREG programme is funded by the European Regional Development Fund, and aims to promote cooperation between European regions to achieve greater cohesion between member states in terms of public policy and private initiative [32]. There are three types of programmes, namely cross-border cooperation programmes, transnational cooperation programmes, and interregional programmes.

The University Hospital of Martinique is active at the international level in conjunction with the University of the French West-Indies. This partnership takes several forms, including for example shared procedures, exchange of practices and information, joint reception of foreign delegations, implementation of joint missions or projects, and bilateral communication regarding inward and outward mobility of medical personnel holding academic posts.

The main issues at stake in terms of cooperation in cancer for the University Hospital of Martinique are the continuing medical education of its healthcare professionals, sharing of experience, access to innovative therapies and new technologies, as well as the development of networks of competence.

## Global issues in international cooperation and obstacles to cooperation

**Human relations** The majority of the difficulties with co-operation arise from the fact that human relations can be complex, socio-cultural environments differ, and healthcare and demographic contexts are heterogeneous across the Caribbean. These differences can complement each other, but also raise issues that need to be taken into account to optimise cooperative missions. The impact of a
project on the key stakeholders must be evaluated in ad-
vance, as well as after completion of the cooperation.

The availability of healthcare staff is a major issue. In-
deed, structuring a network for cooperation relies on the
healthcare staff working within the University Hospital
of Martinique, which in turn implies that these staff
members be released from their ordinary duties to per-
form missions outside of Martinique in the framework
of the cooperation. The healthcare teams need to have
enough staff members to make it possible to attend to
the needs of the other partners and contribute to the
success of the project.

Considering that the Caribbean area is largely English-
speaking, Martinique must make a concerted effort to
find its place among partners that do not speak French.
The healthcare professionals involved must therefore be
proficient in comprehension of oral and written English
to enable clinical examinations or exchanges with ad-
ministrative or diplomatic personnel, but also to speak
publicly in international scientific meetings (press con-
ferences, congresses, scientific articles). The language
barrier is a major obstacle that can be removed by pro-
viding training to healthcare professionals in cooperative
missions on site in partner countries. Furthermore, co-
operative efforts cannot be designed as “person-
dependent” initiatives, given the high turnover of med-
ical personnel in the French West-Indies, and the con-
cept of dedicated teams is important for a long-term
perspective.

**Organisational barriers** Our experience has brought us into contact with a range of different types of cooperation projects, and organisational constraints are common to all missions. Indeed, every mission requires at least 6 months of preparatory groundwork to deal with regulatory demands (visas, ministerial authorisations), and ensure availability of the teams, but also to organise an agenda for the partnership work that will maximise the utility of the mission for all the stakeholders involved. Nonetheless, experience has shown that even missions organised in emergency contexts, by an experienced team with the necessary qualifications to manage emergencies and diplomacy, can be sufficiently satisfactory. In emergency situations, the teams are under pressure to optimize management of the resources allocated, and meet objectives that must be clear and achievable.

**Financial barriers** Managing the financial constraints is an essential part of the preparatory work for any co-operative mission, given the absence of dedicated funding for cooperation in the course of routine hospital activity in France. Apart from funding opportunities such as grants for missions of general interest, or projects funded through the INTERREG programme, few

teams avail of funds for cooperation. The role of associa-
tions working to promote scientific research can be im-
portant in multicentre projects. Non-governmental
organisations can also provide support for major events.

Risk management: taking account of a force majeure

There are a number of unexpected events that may pro-
foundly affect project management. In around 60% of
cases, the likelihood of such events can be studied in ad-
vance. In this regard, the Caribbean is at risk of extreme
meteorological events including cyclones, earthquakes
and to a lesser extent, tsunamis. The risk is at its great-
est during the rainy season, i.e. from the end of June to
October. During these months, teams should avoid plan-
ning any large-scale cooperative missions, given the pro-
hibitive cost of cancellations. Similarly, plane accidents
can perturb air traffic and/or lead to re-routing of flights
back to France or towards the United States, thereby in-
creasing the costs and duration of transit inestimably.

Hurricane Maria (a Category 4 storm in 2017) is a prime example illustrating the vulnerability of the Caribbean area to high-impact weather-related events, after which cooperation in terms of humanitarian aid becomes the priority for healthcare establishments.

Other unpredictable risks include anecdotal events
such as losing one's passport prior to an international
flight, an acute health event or accident on site requiring
repatriation in a wheelchair, or detention at customs at
entry into a country because of incomplete administra-
tive procedures. The lessons learned from these situa-
tions make it possible to improve and better plan for
future missions. Above all, these experiences underline
that a key player in resolving cross-border incidents is
the French embassy (for issuance of an emergency pass-
port, for aid with repatriation etc.). Therefore, it is fund-
damentally important to inform the French embassy at
the destination about the mission and its participants, to
anticipate any unforeseen incidents that may require
diplomatic intervention.

Perspectives for development and integration of
innovative cooperative projects

Development of e-health and innovation as tools for
cooperation

The healthcare sector is a major source of attractivity and
influence. Excellence in healthcare training for public
health greatly boosts attractiveness and opportunities for
collaboration in an environment where pooling of re-
sources (human and material) is strongly encouraged. E-
health is defined as the application of information and
communication technologies to the field of health and
well-being, while m-health (i.e. via smartphones and other
connected devices) is currently offering innovative oppor-
tunities for the development of collaborative projects with
patients, patient associations and healthcare professionals
in interaction with healthcare provision services.

The growing bilateral relations between OECS coun-
tries will be an important lever in enhancing the attract-
iveness of the region for young researchers and
healthcare professionals, through the creation of a centre
of attraction, namely a digital platform for medical re-
search and exchange, under the auspices of the
Martinique General Cancer Registry and the Oncology –
Haematology – Urology division of the University Hos-
pital of Martinique.

This innovative, collaborative data platform, the
“Martinique Cancer Data Hub”, comprising both e-
health and e-learning options, will provide dedicated in-
terconnected interfaces and an integrated database sys-
tem, offering a unique experience and outstanding
learning opportunities for healthcare professionals, pa-
tients and their relatives as well as regional health au-
thorities. Each participant will contribute to a particular
set of values, with an overall architecture that guarantees
the quality and security of integrated health data
management.

In the long term, this should facilitate surveillance and
data collection at a population level, yet using a person-
centred approach. In view of the private nature of the
data concerned, an essential preliminary step is to lay
down a strict legal framework for technological innova-
tions in health, before moving forward with large-scale
projects in multicentre initiatives with other countries of
the OECS or Caribbean.

The objective of the interactive “Martinique Cancer Data Hub” platform is to enable efficient analysis of health data for surveillance and research in oncology and haematology. This secure internet platform plans to:

- Create e-cohorts of patients for the main cancer types (prostate, breast, colorectal...);

- Model the life pathways and aging pathways of patients according to treatment type, age at diagnosis or cancer stage;

- Investigate overall and specific quality of life within these cohorts;

- Propose projects in the field of pharmaco-
  epidemiology, to evaluate the real-life efficacy of
  treatments;

- Create a consortium of researchers (mapping the major players in the field), and disseminate their scientific publications;

- Inform and recruit patients who might participate in innovative clinical trials, putting the patient at the heart of the research.

Through these innovative initiatives, existing working
partnerships between our medical and scientific teams

and our international colleagues will be strengthened
and cemented. This project will provide answers to pri-
ority issues in the field of health, and will also promote
French expertise in this area.

Quality of life and cancer: example of a highly relevant
topic for scientific cooperation in the field of cancer

Incidence and mortality from prostate cancer in Martinique [7, 33] count among the highest in the world. With this in mind, we developed a collaborative project focused on overall quality of life, and quality of sexual health [8], by implementing quality of life questionnaires in routine practice during the constitution of a cohort of patients with prostate cancer. Health-related quality of life is a multidimensional concept that encompasses the physical, mental and social domains, but also biological and clinical domains. To implement federative projects in the field of cancer in the elderly in the framework of healthcare cooperation across the Caribbean, a Task Force was created to strengthen cooperative efforts between cancer registries [22]. This consortium of researchers, all specialized in cancer surveillance, plans to implement larger scale multicentre epidemiological studies, as well as clinical trials and quality of life studies in cancer patients.

In this regard, the Cancer Registry of Martinique has
proposed a roadmap for the set-up of a network for sci-
entific, technical and clinical collaboration in cancer in
the Caribbean. Other areas such as communication,
methodological support and teaching could also be ad-
dressed within the network. In this way, data from Fran-
ce's territories in the Caribbean could be utilized for
scientific purposes, while also creating a bridge between
the Caribbean and the Franco-European zone (Fig. 1).

Utility of integrated action in a strategic plan for cancer
surveillance in the Caribbean

The International Agency for Research on Cancer (IARC) has established Regional Hubs to oversee activities with the leading countries in their catchment area. The aim is to help the countries in the Hub to develop their own plans to fight cancer, by providing methodological support and by helping them to acquire the necessary knowledge. In each region, the core activities comprise:1) Providing local training courses and individualized support; 2) Promoting research; 3) Assisting in the development of regional networks and facilitating communication. According to information available on the Global Initiative for Cancer Registry Development (GICR) [34], the GICR will be operational in 20 low and middle-income countries by 2020, and 30 additional countries by 2025. At a regional level, a support centre is ongoing for all the cancer registries of the Caribbean
<figure><img src="image_4.png" /><figcaption>**Fig. 1** Scientific cooperation in the field of cancer in Martinique</figcaption></figure>

with the creation of the Caribbean Hub, and the con-
tribution of the Martinique Cancer Registry has been
highlighted through a partnership agreement with the
GICR, in view of the high quality of this registry
within the Caribbean.

Scientific collaboration for cancer surveillance in the Caribbean through a regional network of cancer registries was initiated with the advent of the registry in 1983. On-site visits started in the 1990s, and the most recent visits in 2015, 2016 and 2017 have helped renew cooperation with Puerto Rico and Cuba, and promote partnerships with other countries of the OECS, as well as with the cancer registries of Guadeloupe and French Guyana. A roadmap has been developed, with step-by-step plans to achieve an optimal cancer research system at local level (in Martinique), at a regional level (across the French West-Indies) and at national and international levels.

Since the Region of Martinique joined the OECS,
the example of the cancer registry network as a
model of cooperation for cancer within the Caribbean
has been presented at the first conference of Minis-
ters for Health of the OECS member countries in
2014 in Saint Vincent. Martinique's geographical pos-
ition enables it to propose support for cancer registry
development in the neighbouring islands. Thanks to
this project, it is hoped that improvements in epi-
demiological knowledge and public health planning
will be achieved. Cancer registries currently provide
high-quality data about incidence and mortality at

international level (within the IARC). Cooperation
with the OECS countries and the wider Caribbean
area would meet the desired objectives in terms of
support for the development of cancer surveillance
activities, and training of healthcare professionals
[35] through the creation of a hub for the develop-
ment of cancer registries [36].

Conclusion

Collaborative projects aimed at sustaining cancer re-
search activities in the Caribbean, through the develop-
ment of a digital platform, will help to identify the
clinical, demographic, socio-economic and organisa-
tional determinants that give rise to the heterogeneity in
cancer across the Caribbean. Thanks to the cooperative
missions already carried out, the General Cancer Regis-
try of Martinique has strengthened cooperation with
Puerto Rico, Cuba, Dominican Republic, Saint Lucia, as
well as with Guadeloupe and French Guyana in the con-
text of the French Network of Cancer Registries. The full
spectrum of these cooperative initiatives carried out be-
tween 2015 and 2019 have been presented in inter-
national scientific meetings, and have led to renewed
cooperation with the registries of the Pan-American
zone in the framework of working groups. These collab-
orative exchanges will continue throughout 2020 and
will lead to the implementation of mutual research pro-
jects across a larger population basin, integrating e-
health approaches and epidemiological e-cohorts.
**Abbreviations**

AFRO: Regional Office for Africa of the World Health Organization;
GICR: Global Initiative for Cancer Registry Development; IARC: International Agency for Research on Cancer; INTERREG: European Union funding programme for cross-border and inter-regional cooperation;
OECS: Organisation of Eastern Caribbean States; PAHO: Pan American Health Organization; WHO: World Health Organization

**Acknowledgements**

The authors thank Santé Publique France, INCa, University Hospital of Martinique, the International Agency for Research on Cancer, the IARC Caribbean Cancer Registry Hub and all those who contributed to the recording of cancer data in the registries. We thank Fiona Ecarnot, PhD (EA3920, University Hospital Besançon, France) for editorial assistance.

**Authors' contributions**

CJ, JVB were major contributors in writing the manuscript, made substantial contributions to conception and design, MD, CC, TA revised it critically for important intellectual content. ES, MD, TA, MV,VH, NG, SB, EP, AAF, FN, NL, XP, PE made substantial contributions to conception and design; and revised it critically for important intellectual content. All authors read and approved the final manuscript.

**Funding**

The Martinique Cancer Data Hub project was funded by the European Regional Development Funds, ERDF MQ0019171 and the Martinique Territorial Authority (CTM, Collectivité Territoriale de la Martinique).

**Availability of data and materials**

Not applicable.

**Ethics approval and consent to participate**

Not applicable.

**Consent for publication**

Not applicable.

**Competing interests**

The authors declare that they have no competing interests.

**Author details**

¹CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 1441 Registre des cancers, Martinique F-97200, France. ²CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF3636 INTERREG Surveillance du Cancer Oncofertilité, F-97200 Martinique, France. ³CHU de Martinique, Direction de la Recherche, UF 3603, Unité de Soutien Méthodologique à la Recherche, Martinique F-97200, France. ⁴CHU de Martinique, Direction de la Recherche, UF 3163, Délégation de la Recherche et de l'innovation, Martinique F-97200, France. ⁵CHU de Martinique, Pôle de Biologie, Laboratoire de Virologie, F-97200 Martinique, France. ⁶CHU de Martinique, Pôle de Biologie, Laboratoire d'anatomopathologie, F-97200 Martinique, France. ⁷CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, F-97200 Martinique, France. ⁸CHU de Martinique, Centre de Données Cliniques, F-97200 Martinique, France. ⁹CHU de Martinique, Pôle de Médecine, Service de Maladies Infectieuses, F-97200 Martinique, France. ¹⁰INSERM, U1099, F-35000 Rennes, France. ¹¹Université de Rennes 1, LTSI, F-35000 Rennes, France. ¹²CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 3596 Recherche en Cancérologie Hématologie, F-97200 Martinique, France.

Received: 22 October 2019 Accepted: 20 February 2020

Published online: 04 March 2020

**References**

1. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian Cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012;104(2):125-32 PubMed PMID: 22228146. Pubmed Central PMCID: PMC3260132. Epub 2012/01/10. eng.

2. O C. Attentes des ARS en matière de données de surveillance épidémiologique des cancers. Saint-Maurice: Santé publique France. 2017.

3. INSEE. Recensement de la population en Martinique La population martiniquaise à son niveau le plus bas depuis 1997 2017.

4. Jeanne-Rose M. Seniors en Martinique: Un enjeu économique 2010. Available from: https://www.insee.fr/fr/statistiques/2128984. Accessed 27 Feb 2020.

5. Thrift AP. The epidemic of oesophageal carcinoma: where are we now? Cancer Epidemiol. Apr. 2016;41:88-95 PubMed PMID: 26851752. Epub 2016/ 02/07. eng.

6. Joachim-Contaret C, Véronique-Baudin J, Macni J, Ulric-Gervaise S, Cariou M, Billot-Grasset A. Chatignoux É. Estimations régionales et départementales d'incidence et de mortalité par cancers en France, 2007-2016. Martinique. Saint-Maurice: Santé publique France; 2019. p. 106.

7. Joachim C, Veronique-Baudin J, Ulric-Gervaise S, Macni J, Almont T, Pierre-Louis O, et al. Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean. BMC Cancer. 2018;18:1130 PubMed PMID: 30445934. English.

8. Joachim C, Ulric-Gervaise S, Drame M, Macni J, Escarmant P, Veronique-Baudin J, et al. Long-term survival of patients with prostate cancer in Martinique: results of a population-based study. Cancer Epidemiol. 2019;59: 193-8 PubMed PMID: 30825842. Epub 2019/03/03. eng.

9. Deloumeaux J, Bhakkan B, Eyraud R, Braud F, Manip M'Ébobisse N, Blanchet P, et al. Prostate cancer clinical presentation, incidence, mortality and survival in Guadeloupe over the period 2008–2013 from a population-based cancer registry. Cancer Causes Control. 2017;28(11):1265–73. https://www.ncbi.nlm.nih.gov/pubmed/?term=Prostate+cancer+clinical+presentation%2C+incidence%2C+mortality+and+survival+in+Guadeloupe.

10. Melan K, Janky E, Macni J, Ulric-Gervaise S, Dorival MJ, Veronique-Baudin J, et al. Epidemiology and survival of cervical cancer in the French west-indies: data from the Martinique Cancer registry (2002-2011). Glob Health Action. 2017;10:1337341 PubMed PMID: 28649938. English.

11. Mallick S, Romana M, Blanchet P, Multigner L. GSTM1 and GSTT1 polymorphisms and the risk of prostate cancer in a Caribbean population of African descent. Urology. 2007;69(6):1165-9 PubMed PMID: 17572208. Epub 2007/06/19. eng.

12. Emeville E, Broquere C, Brureau L, Ferdinand S, Blanchet P, Multigner L, et al. Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Caribbean population of African descent. PLoS One. 2014;9(9):e107275 PubMed PMID: 25198353. Pubmed Central PMCID: PMC4157893. Epub 2014/09/10. eng.

13. Multigner L, Ndong JR, Giusti A, Romana M, Delacroix-Maillard H, Cordier S, et al. Chlordecone exposure and risk of prostate cancer. J Clin Oncol. 2010; 28(21):3457-62. https://www.ncbi.nlm.nih.gov/pubmed/20566993.

14. Multigner L, Kadhel P, Rouget F, Blanchet P, Cordier S. Chlordecone exposure and adverse effects in French West Indies populations. Environ Sci Pollut Res Int. 2016;23(1):3–8 PubMed PMID: 25940496. Pubmed Central PMCID: PMC4712216. Epub 2015/05/06. eng.

15. INCa. Plan Cancer 2014-2019 2014. Available from: http://www.e-cancer.fr/ Expertises-et-publications/Catalogue-des-publications/Plan-cancer-2014-2019. Accessed 27 Feb 2020.

16. Martinique A. Projet Régional de Santé 2018-2022: Lancement de la consultation réglementaire. Available from: https://www.martinique.ars.sante.fr/projet-regional-de-sante-2018-2022-lancement-de-la-consultation-reglementaire. Accessed 27 Feb 2020.

17. Martinique A. SCHEMA REGIONAL D'ORGANISATION DES SOINS 2011/2016. Available from: https://www.martinique.ars.sante.fr/le-projet-regional-de-sante-de-martinique-une-ambition-collective. Accessed 27 Feb 2020.

18. Ministère de l'Europe et des Affaires Etrangères. La Stratégie de santé mondiale de la France; 2017. Available from: https://www.diplomatie.gouv. fr/fr/photos-videos-publications-infographies/publications/enjeux-planetaires-cooperation-internationale/fiches-reperes/2017/article/strategie-de-la-france-en-sante-mondiale-2017-2021. Accessed 27 Feb 2020.

19. La Stratégie Santé Outre mer 2016. Available from: https://www.martinique.ars.sante.fr/la-strategie-sante-outre-mer-0. Accessed 27 Feb 2020.

20. O C. Attentes des ARS en matière de données de surveillance épidémiologique des cancers. Saint-Maurice: Santé publique France; 2017.p. 23. Available from: http://www.orsnpdc.org/2017/02/22/a-lire-enquete-de-sante-publicque-france-attentes-ars-matieres-de-donnees-cancers/. Accessed 27 Feb 2020.

21. Martinique to become the First French Territory to join the Organization of Eastern Caribbean States OECS; 2015. Available from: http://www.oecs.org/ economic-union-press/937-martinique-to-become-the-first-french-territory-
to-join-the-organization-of-eastern-caribbean-states-oecs?highlight=WytYXJ0aW5pcXVIIID=sthash.q7QhVqAJ.dpuf. Accessed 27 Feb 2020.

22. Joachim C, Veronique-Baudin J, Vinh-Hung V, Contaret C, Macni J, Godaert L, et al. Building capacity for cancer surveillance and public health research: The Cancer Task Force Project for Cooperation in the Caribbean and Aging Research. Journal of global health. 2019;9(2):020304. PubMed PMID: 31360443. Pubmed Central PMCID: PMC6642813 www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author), and declare no competing interests. Epub 2019/07/31. eng.

23. DREES. Les établissements de santé dans les départements et régions d'outre-mer: activité et capacités. 2017.

24. Activité de cancérologie pour les résidents des départements et régions d'outre-mer, période 2011-2014: Fiche d'analyse, collection Les Données, INCa, juin 2019.

25. Resiere D. Inter-regional medical cooperation in the Caribbean: a major asset for the influence of the French medicine. Medecine Et Sante Tropicales. 2016;26(3):234-7 PubMed PMID: 27694072. Epub 2016/10/04. La cooperation inter-regionale dans la Caraibe: un atout majeur pour le rayonnement de la medecine francoise. eng.

26. Spence D, Dyer R, Andall-Brereton G, Barton M, Stanway S, Argentieri MA, et al. Cancer control in the Caribbean island countries and territories: some progress but the journey continues. The Lancet Oncology. 2019;20(9):e503-e21 PubMed PMID: 31395473. Epub 2019/08/10. eng.

27. Spence D, Argentieri MA, Andall-Brereton G, Anderson BO, Duggan C, Bodkyn C, et al. Advancing cancer care and prevention in the Caribbean: a survey of strategies for the region. Lancet Oncol. 2019;20(9):e522-e34 PubMed PMID: 31395471. Epub 2019/08/10. eng.

28. Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013;14(5):391-436. https://www.ncbi.nlm.nih.gov/pubmed/23628188.

29. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023-75 PubMed PMID: 29395269. English.

30. Denburg A, Cuadrado C, Alexis C, Klussmann FA, Zamora JCB, Bodkyn C, et al. Improving childhood cancer care in Latin America and the Caribbean: a PAHO childhood Cancer working group position statement. Lancet Oncol. 2017;18(6):709-11 PubMed PMID: 28593842. Epub 2017/06/09. eng.

31. Adler E, Alexis C, Ali Z, Allen U, Bartels U, Bick C, et al. Bridging the distance in the Caribbean: telemedicine as a means to build capacity for care in paediatric cancer and blood disorders. Stud Health Technol informatics. 2015;209:1-8 PubMed PMID: 25980698. Epub 2015/05/20. eng.

32. Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154(2):360-373. PubMed PMID: 28823862. Pubmed Central PMCID: PMC5836473. Epub 2017/08/22. eng.

33. Joachim C, Veronique-Baudin J, Ulric-Gervaise S, Pomier A, Pierre-Louis A, Vestris M, et al. Cancer burden in the Caribbean: an overview of the Martinique Cancer Registry profile. BMC Cancer. 2019;19(1):239.

34. GICR IARC. Available from: http://gicr.iarc.fr/fr/Actions. Accessed 27 Feb 2020.

35. Spence D, Dyer R, Andall-Brereton G, Barton M, Stanway S, Argentieri MA, et al. Cancer control in the Caribbean island countries and territories: some progress but the journey continues. Lancet Oncol. 2019; PubMed PMID: 31395473. Epub 2019/08/10. eng.

36. IARC C-. IARC Caribbean Cancer Registry Hub; 2018 [cited 2018 08302018]. Available from: http://caribbeancrh.carpha.org/. Accessed 27 Feb 2020.

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Ready to submit your research? Choose BMC and benefit from:

* fast, convenient online submission

* thorough peer review by experienced researchers in your field

* rapid publication on acceptance

* support for research data, including large and complex data types

* gold Open Access which fosters wider collaboration and increased citations

* maximum visibility for your research: over 100M website views per year

At BMC, research is always in progress.

Learn more biomedcentral.com/submissions

<figure><img src="image_5.png" /></figure>